Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
19.8M
-
Shares change
-
-1.25M
-
Total reported value, excl. options
-
$69.6M
-
Value change
-
-$7.58M
-
Put/Call ratio
-
0.54
-
Number of buys
-
41
-
Number of sells
-
-28
-
Price
-
$3.52
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2014
102 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2014.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.8M shares
of 119M outstanding shares and own 16.57% of the company stock.
Largest 10 shareholders include FMR LLC (3.21M shares), LANSDOWNE PARTNERS (UK) LLP (2.32M shares), BVF INC/IL (1.53M shares), BlackRock Institutional Trust Company, N.A. (1.43M shares), VANGUARD GROUP INC (1.26M shares), D. E. Shaw & Co., Inc. (942K shares), BlackRock Fund Advisors (816K shares), WASATCH ADVISORS INC (655K shares), IRONWOOD INVESTMENT MANAGEMENT LLC (597K shares), and State Street Corp (503K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.